CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2017. The put-call ratio across all filers is 15.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $7,294,000 | -6.1% | 61,603 | -6.3% | 0.00% | 0.0% |
| Q4 2020 | $7,766,000 | -4.0% | 65,756 | -9.6% | 0.00% | -25.0% |
| Q3 2020 | $8,088,000 | +11.9% | 72,771 | +2.9% | 0.00% | +33.3% |
| Q2 2020 | $7,228,000 | -3.3% | 70,739 | +2.1% | 0.00% | -25.0% |
| Q1 2020 | $7,474,000 | +2.8% | 69,254 | +10.9% | 0.00% | +33.3% |
| Q4 2019 | $7,269,000 | +4.4% | 62,459 | +2.7% | 0.00% | -25.0% |
| Q3 2019 | $6,965,000 | +2995.6% | 60,844 | +2481.4% | 0.00% | – |
| Q2 2019 | $225,000 | +4.7% | 2,357 | 0.0% | 0.00% | – |
| Q1 2019 | $215,000 | +20.1% | 2,357 | 0.0% | 0.00% | – |
| Q4 2018 | $179,000 | -5.3% | 2,357 | 0.0% | 0.00% | – |
| Q3 2018 | $189,000 | +1.1% | 2,357 | +25.2% | 0.00% | – |
| Q2 2018 | $187,000 | -22.1% | 1,882 | -36.5% | 0.00% | – |
| Q1 2018 | $240,000 | +2.6% | 2,966 | 0.0% | 0.00% | – |
| Q4 2017 | $234,000 | -14.6% | 2,966 | 0.0% | 0.00% | – |
| Q3 2017 | $274,000 | – | 2,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 149,457 | $11,773,000 | 6.29% |
| INDUS CAPITAL PARTNERS, LLC | 330,339 | $26,021,000 | 2.54% |
| Perpetual Ltd | 129,799 | $10,215,000 | 1.32% |
| Black Creek Investment Management Inc. | 396,525 | $31,234,000 | 1.18% |
| RUDMAN ERROL M | 28,701 | $2,261,000 | 1.10% |
| COMGEST GLOBAL INVESTORS S.A.S. | 635,752 | $50,078,000 | 1.09% |
| Antipodean Advisors LLC | 15,000 | $1,182,000 | 0.96% |
| Hillhouse Capital Management | 618,391 | $48,711,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 215,866 | $17,004,000 | 0.49% |
| Temasek Holdings (Private) Ltd | 990,000 | $77,982,000 | 0.48% |